Psychedelic-assisted therapy is making its way through the established medical system’s approval process and moving towards becoming an available treatment for conditions such as PTSD and Depression. This comes after years of prohibition of psychedelics through international drug conventions and local laws often disproportionately enforced in marginalized communities. As states and regulatory bodies consider making psychedelic-assisted therapy available, key social justice considerations come into focus, particularly around healthcare disparities and access to treatment, medicalization of plants that certain communities consider sacred, oppressive psychiatric treatments, and stigma experienced by people who use drugs.
The webinar series will cover a range of topics about both the present challenges and future opportunities for addressing social injustice in the field of psychedelic medicine, focusing on the role of the clinician’s voice in the context of the larger healthcare system. The instructors and panelists will contribute their own unique perspectives and insights into the social justice implications of psychedelic-assisted therapy, research, and treatment. Throughout the series, participants will be encouraged to bring curiosity and openness to their own experiences, with a focus on developing insight and understanding based therein. To encourage ongoing reflection and engagement with the material participants will be invited to complete various exercises to clarify their reaction to the material, what they have learned and how they desire to incorporate these insights into their lives going forward.
- Critique the implications of drug policy that impact marginalized populations’ access to psychedelic-assisted therapy.
- Describe the mental health and policy barriers that perpetuate stigma and inequitable access to psychedelic-assisted therapy.
- Explain the ways in which bias against individuals with mental illness are used to invalidate their perspectives, and how this relates to psychedelic-assisted therapy.
- Analyze the role of ethnic and racial identity in psychedelic-assisted therapy research.
- Analyze Intersection between research, policy, corporatization of psychedelics and its impact.
- Describe current psychedelic decriminalization efforts in the US and their relationship to existing drug and religious use policies as well as its impact on indigenous communities.
- Describe the role of gender within psychedelic therapist dyads, and between dyads and participants.
- Demonstrate knowledge of unique aspects of PTSD in military populations that may impact their treatment with psychedelic-assisted therapy.
- Explain the role and application of leading ethical guidelines for psychedelic-assisted therapy.
- Demonstrate knowledge of controversies related to therapist training, as well as therapist self-disclosure of personal experience with psychedelics.
- Fluence International, Inc. is approved by the American Psychological Association to sponsor continuing education for psychologists. Fluence maintains responsibility for this program and its content.
- Fluence International, Inc. is recognized by the New York State Education Department’s State Board for Mental Health Practitioners as an approved provider of continuing education for licensed mental health counselors. #MHC-0232.
- Fluence International, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0674.
- Fluence International, Inc. is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0167.
- The Department’s approval of a provider of continuing education does not constitute the Department’s endorsement of the content, positions or practices that may be addressed in any specific continuing education course offered by the approved provider.
- For questions about continuing education and receiving your CE Certificate or Certificate of Attendance, contact email@example.com. You can also navigate to the FAQs page for more information about our courses/events.